Close

More on STIM

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+23.7% Growth)
- Ratings (6.0 Score)

Upcoming Events

- Earnings (5/7/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Neuronetics Inc. (NQ:STIM)
Delayed: 3.80 -0.03 (0.78%)
Prev. Close $3.83  
Open$3.78 
52 Wk High$ 
52 Wk Low$ 
Day High$4.04 
Day Low$3.76 
P/E N/A  
EPS$ 
Volume48,572 

Friends, Peers and Foes (?): GUD, KERX, FRZ, ECTY, NPNT (more...)

Apr 11, 2024 04:05 PM Form DEFA14A Neuronetics, Inc.
Apr 11, 2024 04:02 PM Form DEF 14A Neuronetics, Inc. For: May 30
Apr 10, 2024 08:39 AM Neuronetics Inc. (STIM) Says New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
Apr 10, 2024 08:31 AM New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
Apr 1, 2024 05:31 PM Form SC 13G Neuronetics, Inc. Filed by: Divisadero Street Capital Management, LP
Mar 28, 2024 04:01 PM Form 8-K Neuronetics, Inc. For: Mar 25
Mar 27, 2024 04:30 PM Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mar 25, 2024 04:59 PM Form 8-K Neuronetics, Inc. For: Mar 25
Mar 25, 2024 08:33 AM Neuronetics Inc. (STIM) Advanced Therapy Receives FDA Clearance
Mar 25, 2024 08:30 AM NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
View All Articles

Entities mentioned with STIM

View All Entities